Atlas Trials

Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity

Clinical trial NCT03890614 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03890614
Sponsor
Wake Forest University Health Sciences
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Hematologic Malignancy
Start date
2019-05-16
Primary completion
2027-02-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.